Development and external validation of a predictive model for lung metastases in kidney cancer based on clinical and laboratory features
Open Access
- 14 August 2025
- journal article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 25 (1) , 293
Abstract
Lung metastases (LMs) are common and clinically significant in kidney cancer, contributing to poor prognosis and limited treatment response. Early detection of patients at high risk for LMs is crucial for developing personalized treatment strategies. This retrospective study included 2652 patients with kidney cancer, pathologically confirmed, from two medical centers between 2000 and 2020. A training cohort (n = 1500) was used to develop a predictive model for LMs based on clinical, pathological, and laboratory variables. Multivariate logistic regression was applied to identify independent predictors, and a nomogram was constructed. Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration plots, probability density functions (PDFs), and decision curve analysis (DCA). An external validation cohort (n = 1152) was used to assess generalizability. Family cancer history, advanced T stage, and N nodal stage were identified as independent predictors of LMs. The nomogram demonstrated excellent discrimination in the training cohort (AUC = 0.938) and moderate performance in the validation cohort (AUC = 0.883), outperforming individual variables. Calibration analysis showed good agreement between predicted and observed probabilities. Patients with LMs had significantly worse overall survival than those without (p < 0.001). DCA validated the nomogram's greater clinical value over treat-all or treat-none approaches. This nomogram-based model offers an efficient and accessible tool for the early detection of kidney cancer patients at risk for LMs. It enables individualized risk stratification and may assist in optimizing clinical decision-making and improving patient outcomes. Further prospective validation is warranted.Keywords
Funding Information
- National Natural Science Foundation of China (82473192)
This publication has 32 references indexed in Scilit:
- A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinomaCancer Science, 2012
- Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary ReviewEuropean Urology, 2011
- Prostaglandin E2 Regulates Renal Cell Carcinoma Invasion through the EP4 Receptor-Rap GTPase Signal Transduction PathwayJournal of Biological Chemistry, 2011
- Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examinationEuropean Journal of Cancer, 2011
- Receiver Operating Characteristic Curve in Diagnostic Test AssessmentJournal of Thoracic Oncology, 2010
- Prognostic factors in renal cell carcinomaWorld Journal of Urology, 2010
- Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasisClinical & Experimental Metastasis, 2009
- pVHL co‐ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear‐cell renal cell carcinomaThe Journal of Pathology, 2007
- Receiver-Operating Characteristic Analysis for Evaluating Diagnostic Tests and Predictive ModelsCirculation, 2007
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006